İndekslere Göre Yayın Sayıları
4 indeks
32
SCI-E
16
ESCI
6
TR Dizin
4
Diğer
Makale Bilgileri
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
1
Prevalence, predictors, and clinical outcomes of heart failure in patients with atrial fibrillation treated with factor Xa inhibitors
2
Rationale and design of the Türkiye Heart Failure (TURK-HF) Registry
3
Clinical management strategies of cardiologists in heart failure with reduced ejection fraction in Türkiye
4
Real-world data on empaglifozin and dapaglifozin use in patients with HEART failure: The RED-HEART study
5
Incidence and predictors of clinical outcomes in real-life patients with atrial fibrillation treated with oral factor Xa inhibitors: The follow-up results of the ANATOLIA-AF study
6
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
7
Clinical management strategies of cardiologists in heart failure with reduced ejection fraction
8
Adherence to current dyslipidemia guIdeline in patients utilizing statins According to risk groups: The AIZANOI study
9
Suboptimal guideline-directed medical therapy and prognosis in patients with heart failure and reduced ejection fraction: The SMYRNA Study
10
Real-world evaluation of anticoagulant treatment patterns in patients with atrial fibrillation: Data from multicenter ROTA study
11
Characteristics of patients with atrial fibrillation on edoxaban treatment in Türkiye: Does health provider type matter? A report from ETAF-TR study
12
PrevAleNce and Associated factors of inappropriaTe dosing of direct oral anticoaguLants In pAtients with Atrial Fibrillation: The ANATOLIA-AF Study
13
Suboptimal guideline adherence is associated with higher MortalitY and hospitalization Rates in patieNts with heArt failure and reduced ejection fraction: The SMYRNA Study
14
Predictors of Major Adverse Cardiac Events After Renal Transplantation
15
The prevalence and clinical features of atrial fibrillation in heart failure patients with midrange ejection fraction in the Turkish population
16
A novel scoring system for the assessment of optimal versus suboptimal adherence to the guideline-directed medical therapy in patients with heart failure and reduced ejection fraction: RBM score
17
CARDIOVASCULAR DISEASE AND RISK FACTORS IN RENAL TRANSPLANT CANDIDATES
18
ASSESMENT OF TOTAL ATRIAL CONDUCTION TIME IN PATIENTS WITH ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA AND CONTROL SUBJECTS
19
GENDER-RELATED CLINICAL AND MANAGEMENT DIFFERENCES IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
20
ADHERENCE TO GUIDELINE-DIRECTED MEDICAL AND DEVICE THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
21
When Popeye had shortness of breath
22
The real - life rate of use of target doses in the treatment of heart failure with reduced ejection fraction: Results from the ATA study
23
Increased inflammatory state can be a predictive marker for acute kidney injury in acute decompansated heart failure patients with preserved ejection fraction
24
SUCCESSFUL MANAGEMENT OF A PATIENT WITH MASSIVE PULMONARY EMBOLISM COMPLICATED WITH CARDIOPULMONARY SHOCK BY IMPLEMENTING EXTRACORPOREAL MEMBRANE OXYGENATION
25
CONCOMITANT SURGICAL TREATMENT OF TIMOMA AND CORONARY ARTERY DISEASE
26
ACUTE CORONARY SYNDROME ASSOCIATED WITH CARFILZOMIB TREATMENT
27
REVERSIBLE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION DUE TO 5-FLUOROURACIL-INDUCED CARDIOTOXICITY
28
A case of atypical clinical presentation of acute aortic syndrome
29
Sliding hiatal hernia mimicking a left atrial mass
30
Successful thrombolysis of a subacute prosthetic valve thrombosis with modified ultra-slow thrombolytic therapy
31
Negative baseline diagnostic imaging does not exclude pulmonary embolism in patients with recurrent syncope
32
Atrial fibrillation and heart failure: double trouble for hospitalized patients with acute decompensated heart failure
33
Improvement of Blood Pressure Control in a Hypertension Unit: A 5-year Follow-up Study in Elderly Hypertensive
34
Demographic and Clinical Features of Elderly Hypertensive Patients
35
Predictive Value of Cha2ds2-vasc and Cha2ds2-vasc-hs Scores for Failed Reperfusion after Thrombolytic Therapy in Patients with St-elevation Myocardial Infarction
36
A giant pericardial cyst as a rare cause of shortness of breath
37
A ventricular septal defect restricted by the tricuspid septal leaflet and discrete subaortic membrane presenting with high-grade atrioventricular block and syncope
38
A young man with reversible diabetic cardiomyopathy associated with hyperosmolar hyperglycaemic state
39
Two cases with persistent left superior vena cava with absence of right superior vena cava
40
Giant left ventricular pseudoaneurysm presenting with ventricular tachycardia
41
Younger heart failure population with higher in-hospital mortality
42
Unusual Combination of Membranous Ventricular Septal Defect Restricted by the Tricuspit Septal Leaflet, Mitral Valve Prolapse and Congenital Bicuspid Aortic Valve
43
A Historical Electrocardiographic Finding: Masquerading Bundle Branch Block
44
Is there a heart rate paradox in heart transplantation?
45
Electrocardiogram Characteristics in Patients with Slow/Fast Atrioventricular Nodal Reentrant Tachycardia with and without Drug-Induced Type 1 Brugada Pattern
46
Epidemiology of infective endocarditis in a developing country
47
Fifteen Years of Follow-Up For A Pericardial Effusion
48
Giant Left Ventricular Tumor Metastasis Causing Left Ventricular Outflow Tract Obstruction
49
Premature Ventricular Contraction (PVC) Induced Cardiomyopathy with Multiple Prolapse of Cardiac Valves
50
The impact of pre-transplant bundle brunch block on mortality in patients with heart transplant: from one heart to another
51
The effect of obesity on mortality in heart transplant patients
52
FLECAINIDE IS EFFECTIVE IN REVERSING TACHYCARDIA-INDUCED CARDIOMYOPATHY ASSOCIATED WITH ANDERSEN-TAWIL SYNDROME
53
CO-EXISTENCE OF ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA AND BRUGADA SYNDROME
54
A rare synergy in hypertension: Bilateral renal artery stenosis and polycystic kidney disease
55
Yüksek doz propafenon alımına bağlı gelişen kardiyak arrest ve tam iyileşme: Brugada sendromu ya da brugada fenokopisi?
56
Factors affecting survival before and after heart transplantation
57
Preoperative hemodynamic and echocardiographic predictors of right ventricular failure after left ventricular asist device implantation
58
Epidemiological, Clinical Characteristics and Predisposing Factors of Infective Endocarditis: A review of 194 cases
59
Cardiovascular System Effects of Anti-personnel Agents
60
Microbiological Profile, Echocardiographic Characteristics and Early Results of Infective Endocarditis: A Review of 194 Cases at a Tertiary Care Center in Turkey
61
Kalp Transplantasyonuna Köprüleme Tedavisi - Ventriküler Destek Cihazı İmplante Edilen Son Dönem Kalp Yetmezliği Olgusu
Kitap Bölümü Bilgileri
1
Sodyum Glukoz Ko-Transporter ? 2 İnhibitörleri
2
Akut Kalp Yetersizliği
3
KANSER TEDAVİSİ İLE İLİŞKİLİ KARDİYAK DİSFONKSİYON
4
AVRUPA KARDIYOLOJI DERNEGI KARDIYOONKOLOJI KILAVUZUNDA ÖNE ÇIKANLAR
5
Sol Kalp Yetersizliğine Bağlı Gelişen Pulmoner Hipertansiyon
6
Kardiyojenik Şokta Trombolitik Tedavi Yaklaşımları
7
Korunmuş Ejeksiyon Fraksiyonlu Kalp Yetersizliği ve Restriktif Kardiyomiyopati
8
Mitraklip Endikasyonlarında Gri Alanlar
9
Glikojen Depo Hastalıkları
10
Sağ Kalbin Ekokardiyografik Değerlendirilmesi
11
Aritmili Hastanın Değerlendirilmesi
12
Mitokondrial Miyopatiler
13
Kardiyomiyopatiler
14
Yenilenmiş Kalp Yetersizliği Kılavuzlarının Tedavi Tavsiyelerinde İleri Kalp Yetersizliği Tedavisi
1
Türkiye Heart Failure Registry
1
En Başarılı TKD Arşivi Makale Ödülü, 14.11.2025
2
40. Uluslararası Katılımlı Türk Kardiyoloji Kongresi Sözlü Bildiri İkincilik Ödülü, 07.11.2024
3
Yılın En Başarılı Genç Kardiyologları, 01.05.2014
4
30. Uluslararası Katılımlı Türk Kardiyoloji Kongresi Sözlü Bildiri İkincilik Ödülü, 01.01.1970
1
Kalp Yetersizliği Tedavisinin Güncelleri - SGLT2i'leri Beklentilerin Ötesinde mi? - Kardiyovasküler Akademi Kongresi - 2021, - 17/09/2021, KUZEY KIBRIS TÜRK CUMHURİYETİ
2
Akılcı İlaç Sunumu - Kardiyoloji Pratiğinde Olgularla Girişimsel Akademi - Dijital Sempozyum, - 27/02/2021,
3
Cardio-Oncology: Bench to Bed Side - Modifiable Risk Factors for Cardiotoxicity in Cancer Survivors#13;
- 16th International Congress of Update in Cardiology and Cardiovascular Surgery, - 30/10/2020,
4
Future Stars in Cardiology - Atrial Fibrillation in Heart Failure: What Should We Do? - 16th International Congress of Update in Cardiology and Cardiovascular Surgery, - 01/11/2020,
5
Büyük Çalışmalar Büyüteç Altında: PARAGON-HF - Türk Kardiyoloji Derneği Klinik Çalışmalar Uygulama ve Eğitim Proje Grubu Toplantısı, - 29/02/2020,
6
Kardiyomiyotoksisite Tanısında Ekokardiyografi#13;
Öğrenim hedefi: 2D ve 3D Ekokardiyografi, Strain Görüntüleme, Stress Görüntüleme Esasları ve İpuçları, Fusion Görüntüleme - Türk Kardiyoloji Derneği - 6. KardiyoBahar Güncellemesi, - 07/03/2019,
7
Kardiyotoksisite Açısından Riskli Hastanın Belirlenmesi - Türk Kardiyoloji Derneği - 6. KardiyoBahar Güncellemesi, - 07/03/2019,
8
Radyoterapiye Bağlı Kardiyotoksisite ve Hemşirelik Yönetimi#13;
Öğrenim hedefi: Radyoterapiye bağlı oluşan kardiyotoksisitede semptom yönetimi#13;
Umut Kocabaş (Kardiyoloji, Başkent Üniversitesi, İstanbul) - Türk Kardiyoloji Derneği Ulusal KardiyoOnkoloji Toplantısı - KardiyoOnkoloji İstanbul, - 23/11/2019, TÜRKİYE
9
Nadir Görülen Hastalıklar ve İleri Görüntüleme Teknikleri - KardiyoOnkolojide Yenilikler Toplantısı, - 21/12/2018, TÜRKİYE
10
Klinik pratikte zor akla gelen kardiyovasküler ilaç yan etkileri#13;
Öğrenim hedefi: Kardiyovasküler ilaçların zor akla gelen yan etkileri olgu örneği ve görsellerle anlatılacak - 34. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, - 20/10/2018,
11
Tüm Yönleriyle Koroner Anatomi ve Fizyoloji: Bildiğimizi Sandığımız Alan - MRG ve fonksiyonel MRG - Kardiyovasküler Akademi Kongresi - 2017, - 21/09/2017, KUZEY KIBRIS TÜRK CUMHURİYETİ
